Global Multiple Unit Pellet Systems Market Set to Reach USD 5.2 Billion by 2033, Driven by Innovation in Drug Delivery Technologies | FMI

The global multiple unit pellet systems market is experiencing remarkable growth, with its value reaching USD 3.6 billion in 2023. Recent projections indicate this market is poised to continue its upward trajectory, achieving an impressive USD 5.2 billion by 2033, reflecting a Compound Annual Growth Rate (CAGR) of 3.6%. This surge highlights the increasing adoption of MUPS in pharmaceutical applications, driven by their ability to offer advanced drug delivery solutions.

MUPS are revolutionizing the drug delivery landscape, particularly in capsule form. Unlike traditional suspension-based medications, MUPS provide enhanced physicochemical stability, improved ease of ingestion, and more controlled drug release profiles. This innovative technology incorporates a wide range of pelletized dosage forms, including pellets, granules, microcapsules, microspheres, and minitablets. These features not only improve therapeutic outcomes but also increase patient compliance, making MUPS an attractive option for healthcare providers worldwide.

Dive into the Forecasted Expansion of the Multiple Unit Pellet Systems Market Sample Reports!

The growing demand for patient-friendly and efficient drug delivery systems is a major factor contributing to the remarkable growth of the MUPS market. As healthcare providers seek ways to enhance bioavailability and improve patient experiences, MUPS have become increasingly popular. This trend is expected to continue, with significant investments in research and development by key players in the pharmaceutical industry, aiming to further enhance the capabilities of MUPS and expand their applications.

Regional Growth Highlights:

In North America, particularly the United States, the MUPS market is experiencing robust growth. The increasing prevalence of gastrointestinal disorders and a rising need for gastro-resistant medications are expected to drive the market’s growth in the region throughout the forecast period.

India is also projected to witness strong growth, with a notable CAGR between 2023 and 2033. Indian manufacturers are heavily investing in research and development, responding to the growing demand for improved pharmaceutical solutions.

In East Asia, China is expected to see significant expansion in the MUPS market, fueled by its efficient drug production capabilities. The country’s ability to produce medications at remarkably low prices, coupled with an increasing focus on advanced drug delivery technologies, is expected to contribute to the sector’s rapid growth.

As the MUPS market continues to evolve, its expansion will pave the way for groundbreaking advancements in drug delivery, benefiting patients globally.

Key Takeaways:

• The extended-release dosage form segment in the formulation category to grab a share of 47.23% from 2023 to 2033.
• In the dosage form category, the capsules segment acquired a market share of 47.31% between 2023 and 2033.
• The United States multiple unit pellet systems business to acquire a share of 27% by 2023.
• The Germany MUPS industry is to grab a share of 5.2% by 2023.
• Japanese multiple unit pellet systems (MUPS) market to hold a share of 5.6% by 2023.
• Australia MUPS market to acquire a share of 1.8% by 2023.
• Chinese multiple unit pellet systems business to expand at a CAGR of 4.4% through 2033.
• India multiple unit pellet systems industry is to develop at a CAGR of 5.6% from 2023 to 2033.
• United Kingdom MUPS market to evolve at a CAGR of 3.9% through 2033.
• The North America MUPS industry to grab a share of 29.6% by 2023.
• Europe multiple unit pellet systems industry to hold a share of 25.9% by 2023.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape:

Companies are working on obtaining fast-track drug approvals in an effort to diversify their product offerings and establish a strong presence in the multiple unit pellet systems industry.

To increase their market share, these multiple unit pellet systems manufacturers are engaging in several crucial strategies, such as mergers and acquisitions, new product launches, collaborations, research and development expenditure, distribution network expansion, and partnerships.

Companies offer their goods through a variety of channels, including e-commerce websites, retailers, distributors, corporate websites, and final customers.

Recent Development:

• In May 2023, PERRIGO reported that the United States FDA had approved the 20 mg over-the-counter (OTC) mini capsules of meprobamate magnesium. To cure persistent heartburn, take this pill. The item is to be offered for sale under the retailer’s store brand, which is similar to Prilosec OTC.

Vital Multiple Unit Pellet System Manufacturers:

• AstraZeneca plc
• Merck KGaA
• Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
• Galderma SA
• Novartis AG
• GlaxoSmithKline Plc
• Perrigo Company Plc.
• Cipla Ltd.
• Astellas Pharma Inc.
• Takeda Pharmaceutical Company Ltd.
• Eli Lilly and Company
• Dr. Reddy’s Laboratories Ltd.
• Endo International Inc.
• Mylan Pharmaceuticals Inc.
• Teva Pharmaceuticals Ltd.
• AbbVie (Allergan)
• GlaxoSmithKline Plc
• Bayer AG

Key Segments:

By Formulation:

• Extended Release Dosage Form
• Delayed Release Dosage Form
• Delayed Release Orodispersible Dosage Form
• Others

By Dosage Form:

• Tablets
• Capsules
• Sachets
• Others

By Drug Class:

• Anti-Hypertensive
• Proton Pump Inhibitors
• Antibiotics
• Analgesics
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T! +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube